MS Briefs

Researchers Examine Vitamin D, Skin Pigmentation, and Outcomes of Pediatric MS

Dunn C et al. AAN 2019, Abstract S19.007.

Publish date: May 30, 2019

 

Key clinical point : The relationship between vitamin D status and MS outcome in children relates to skin pigmentation.

Major finding : About 46% of children with MS were HLA-DRB1*15 positive.

Study details : A multisite, prospective study of 259 children with MS.

Disclosures: Ms. Dunn had no disclosures, but various coauthors have received compensation from companies such as Novartis, Merck, Teva, Celgene, and Genentech.

Citation: Dunn C et al. AAN 2019, Abstract S19.007 .

Recommended Reading

Alemtuzumab increases the likelihood of disability improvement in MS
ICYMI Multiple Sclerosis
MS significantly affects employment and home activities
ICYMI Multiple Sclerosis
Anxiety and fatigue impair processing speed in MS
ICYMI Multiple Sclerosis
What other drugs do patients take when they start MS therapy?
ICYMI Multiple Sclerosis
MS linked to higher rates of hoarding behavior
ICYMI Multiple Sclerosis
More patients than ever receive DMT within 1 year of MS disease onset
ICYMI Multiple Sclerosis
Pain, fatigue, depression, and anxiety are common in the year after MS diagnosis
ICYMI Multiple Sclerosis
Association between cytomegalovirus and MS varies by region
ICYMI Multiple Sclerosis
Modest evidence for benefit in studies of cannabis in MS
ICYMI Multiple Sclerosis
Why aren’t preferred DMTs prescribed for MS? Neurologists point to insurers, patients
ICYMI Multiple Sclerosis